Biocept
(OTC) BIOCQ
Biocept Financials at a Glance
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
-$8.02M
Net Income (TTM)
-$39.42M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
4527.39 (High)
Dividend
$0.00
Beta (Volatility)
4527.39 (High)
Price
$0.00
Volume
67
Open
$0.00
Price
$0.00
Volume
67
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
May 29, 2026
Dividend
$0.00
Beta (Volatility)
4527.39 (High)
Price
$0.00
Volume
67
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.10
Estimated Earnings Date
May 29, 2026
BIOCQ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biocept
Industry
Biotechnology
Sector
Health CareEmployees
52
CEO
Samuel D. Riccitelli
Website
www.biocept.comHeadquarters
San Diego, CA 92121, US
BIOCQ Financials
Key Financial Metrics (TTM)
Gross Margin
-9.99%
Operating Margin
-123.69%
Net Income Margin
-124.09%
Return on Equity
-138.49%
Return on Capital
-152.53%
Return on Assets
-103.93%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.63M
Volume
67
Avg. Volume
744.194
Financials (TTM)
Gross Profit
-$23.68M
Operating Income
-$41.97M
EBITDA
-$37.09M
Operating Cash Flow
-$17.60M
Capital Expenditure
-$680.00K
Free Cash Flow
-$18.28M
Cash & ST Invst.
$6.63M
Total Debt
$11.59M
Biocept Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$589.00K
N/A
Gross Profit
-$1.96M
N/A
Gross Margin
-3.33%
N/A
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$10.00
N/A
Employees
50
N/A
Net Income
-$3.63M
N/A
EBITDA
-$2.92M
N/A
Quarterly Fundamentals
Total Cash
$6.63M
N/A
Total Debt
$11.59M
N/A
Accounts Receivable
$800.00K
N/A
Inventory
$551.00K
N/A
Long Term Debt
$9.69M
N/A
Short Term Debt
$1.91M
N/A
Return on Assets
-1.04%
N/A
Return on Invested Capital
-1.26%
N/A
Free Cash Flow
-$3.18M
N/A
Operating Cash Flow
-$3.09M
N/A